To view this email as a web page, click here.
Conference Coverage
 
 February 17, 2018
 
Dermatology Times will be reporting from the AAD annual meeting this week in San Diego. Visit our conference news page to follow the developments from the meeting.
 
Vitamin D overload concerns expressed at AAD
There's been much debate in the literature about the need for and role of vitamin D. Now, patients may be taking too much vitamin D, researchers said at AAD 2018 this week.
Learn More.
 
Multidisciplinary care improves patient outcomes
Multidisciplinary skin cancer care is an approach that might not only improve patient outcomes, but also professional satisfaction, researchers reported at AAD 2018 this week in San Diego.
Learn More.
ADVERTISEMENT
 
Spironolactone for hormonal acne
Female patients with hormonal acne that typically flares before or after menstrual cycles may be ideal candidates for spironolactone, said Emmy M. Graber, M.D., president of the Dermatology Institute of Boston who spoke at AAD 2018 in San Diego this week.
Learn More.
ADVERTISEMENT
 
ADVERTISEMENT
Show Your Unexpected. Spray on SERNIVO.
SERNIVO® (betamethasone dipropionate) Spray, 0.05% features a novel lotion-like spray formulation with a balance of high penetration/permeation and low systemic absorption. Learn more
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.